Palvella Therapeutics Stock Market Value
| PVLA Stock | 101.03 10.60 11.72% |
| Symbol | Palvella |
Palvella Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palvella Therapeutics. If investors know Palvella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palvella Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Palvella Therapeutics is measured differently than its book value, which is the value of Palvella that is recorded on the company's balance sheet. Investors also form their own opinion of Palvella Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Palvella Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palvella Therapeutics' market value can be influenced by many factors that don't directly affect Palvella Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palvella Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Palvella Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palvella Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Palvella Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Palvella Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Palvella Therapeutics.
| 10/16/2024 |
| 01/09/2026 |
If you would invest 0.00 in Palvella Therapeutics on October 16, 2024 and sell it all today you would earn a total of 0.00 from holding Palvella Therapeutics or generate 0.0% return on investment in Palvella Therapeutics over 450 days. Palvella Therapeutics is related to or competes with GH Research, ARS Pharmaceuticals, Nanobiotix, ProKidney Corp, Savara, Kura Oncology, and Arbutus Biopharma. Palvella Therapeutics is entity of United States More
Palvella Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Palvella Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Palvella Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.7 | |||
| Information Ratio | 0.1362 | |||
| Maximum Drawdown | 28.65 | |||
| Value At Risk | (8.04) | |||
| Potential Upside | 9.04 |
Palvella Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Palvella Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Palvella Therapeutics' standard deviation. In reality, there are many statistical measures that can use Palvella Therapeutics historical prices to predict the future Palvella Therapeutics' volatility.| Risk Adjusted Performance | 0.1219 | |||
| Jensen Alpha | 0.8454 | |||
| Total Risk Alpha | 0.2609 | |||
| Sortino Ratio | 0.1478 | |||
| Treynor Ratio | (0.75) |
Palvella Therapeutics Backtested Returns
Palvella Therapeutics appears to be very steady, given 3 months investment horizon. Palvella Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12 % return per unit of risk over the last 3 months. By analyzing Palvella Therapeutics' technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please evaluate Palvella Therapeutics' Coefficient Of Variation of 655.23, semi deviation of 4.31, and Risk Adjusted Performance of 0.1219 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Palvella Therapeutics holds a performance score of 9. The company holds a Beta of -1.03, which implies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Palvella Therapeutics are expected to decrease slowly. On the other hand, during market turmoil, Palvella Therapeutics is expected to outperform it slightly. Please check Palvella Therapeutics' treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Palvella Therapeutics' historical price patterns will revert.
Auto-correlation | 0.71 |
Good predictability
Palvella Therapeutics has good predictability. Overlapping area represents the amount of predictability between Palvella Therapeutics time series from 16th of October 2024 to 29th of May 2025 and 29th of May 2025 to 9th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Palvella Therapeutics price movement. The serial correlation of 0.71 indicates that around 71.0% of current Palvella Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.71 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 712.46 |
Palvella Therapeutics lagged returns against current returns
Autocorrelation, which is Palvella Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Palvella Therapeutics' stock expected returns. We can calculate the autocorrelation of Palvella Therapeutics returns to help us make a trade decision. For example, suppose you find that Palvella Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Palvella Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Palvella Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Palvella Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Palvella Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Palvella Therapeutics Lagged Returns
When evaluating Palvella Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Palvella Therapeutics stock have on its future price. Palvella Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Palvella Therapeutics autocorrelation shows the relationship between Palvella Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Palvella Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Palvella Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palvella Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palvella Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palvella Therapeutics Stock:Check out Palvella Therapeutics Correlation, Palvella Therapeutics Volatility and Palvella Therapeutics Alpha and Beta module to complement your research on Palvella Therapeutics. For information on how to trade Palvella Stock refer to our How to Trade Palvella Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Palvella Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.